Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Novartis
Fish and Richardson
Baxter
McKinsey
Teva
AstraZeneca
Cerilliant
Julphar
Harvard Business School

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,738,974

« Back to Dashboard

Summary for Patent: 4,738,974
Title: Base addition salts of omeprazole
Abstract:Novel salts of omeprazole with Li.sup.+, Na.sup.+, K.sup.+, Mg.sup.2+, Ca.sup.2+, Ti.sup.4+, N.sup.+ (R.sup.1).sub.4 or ##STR1## as cation; processes for their preparation thereof, pharmaceutical compositions containing such salts and their use in medicine.
Inventor(s): Brandstrom; Arne E. (Gothenburg, SE)
Assignee: Aktiebolaget Hassle (SE)
Application Number:06/854,739
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;

Drugs Protected by US Patent 4,738,974

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,738,974

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden8301182Mar 04, 1983

International Patents Family Members for US Patent 4,738,974

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Jordan 1425 ➤ Subscribe
Japan S59167587 ➤ Subscribe
Japan H0313233 ➤ Subscribe
South Korea 840008014 ➤ Subscribe
South Korea 870001005 ➤ Subscribe
Lithuania 2253 ➤ Subscribe
Iceland 1363 ➤ Subscribe
Denmark 99584 ➤ Subscribe
Denmark 160044 ➤ Subscribe
Algeria 615 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Queensland Health
US Department of Justice
Baxter
Argus Health
Boehringer Ingelheim
McKesson
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot